I agree. If they know that near term events are going to be bad they could just wait until April to get their options at 50 cents a share. Also, how will it look if the 2nd-line NSCLC investigation returns bad results and these options are being awarded based on their efforts to resolve that issue.
I don't know why they issued the $75 million shelf but I don't consider it a new near term source of dilution. They already have $150 million to burn before they would need to touch these new funds.
I agree FTM, the options will only be valuable if the share price moves up. I think those of us who actually know something about this company realize that the next few weeks and months will be pivotal for the value of our investments. I believe you and other experienced owners have a sense that really good MOS numbers could be coming out in all three of the Phase II studies. Yes, I am including the infamous 2nd Line NSCLC study.
I'm really looking forward to the next few weeks and months. A return to $5 a share could be swift.